CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 911 shares at $5.13 ($4,678)
- 4 Open-market sale Chief Operating Officer sold 2,397 shares at $5.13 ($12,308)
- 4 Open-market sale Chief Business Officer sold 100,000 shares at an average $4.50 ($450,000)
- 4 Open-market sale Chief Patient Supply Officer sold 1,144 shares at $5.13 ($5,874)
- 4 Open-market sale Chief Executive Officer sold 3,236 shares at $5.13 ($16,616)
- 4 Open-market sale Director sold 300,000 shares at an average $4.67 ($1,400,000)
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Patient Supply Officer sold 1,148 shares at $1.20 ($1,378)
Page 21 of 41 · 808 filings